ArticleBMC bioinformatics2026
Mke-resnet: a lightweight and interpretable deep learning framework for efficient RNA m6A site identification.
Article in BMC bioinformatics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
4 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
backgroundN6-methyladenosine ([Formula: see text]) plays a crucial role in enriching RNA functional and genetic information. While deep learning has advanced [Formula: see text] site identification, current state-of-the-art methods, particularly those based on large-scale Pre-trained Language Models (PLMs), often suffer from high computational complexity and over-parameterization, limiting their scalability for genome-wide analysis.
resultsIn this work, we propose MKE-ResNet, an ultra-lightweight end-to-end framework designed to balance predictive performance with extreme computational efficiency. MKE-ResNet integrates a deep residual network with an innovative Multi-Kernel Efficient Channel Attention (MKE-ECA) module to adaptively capture multi-scale sequence patterns. Extensive experiments on 22 datasets demonstrate that MKE-ResNet achieves competitive performance against complex SOTA models (including MST-m6A). Notably, our model exhibits exceptional stability against sequence noise perturbation and demonstrates superior generalization capability on independent test sets (leading in 8 out of 11 cases in terms of AUROC). Furthermore, interpretability analysis reveals that MKE-ResNet moves beyond the static central motif to capture dynamic sequence patterns resembling RBP binding motifs (e.g., SRSF1 and PUM2). The source code and datasets are available at https://github.com/Gxttk/MKE-Resnet.
conclusionsMKE-ResNet provides a biologically interpretable and computationally efficient solution for [Formula: see text] site identification, offering a pragmatic tool for large-scale epitranscriptome screening.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.